Trial Profile
An Exploratory Study of the Role of 18F-FSPG PET/CT Imaging for Cancer Patients Receiving Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jan 2019
Price :
$35
*
At a glance
- Drugs BAY 949392 (Primary)
- Indications Cancer
- Focus Pharmacodynamics
- 11 Dec 2018 Status changed from suspended to completed.
- 15 Feb 2017 Status changed from recruiting to suspended.
- 10 Nov 2015 New trial record